Originally published by our sister publication Infectious Disease Special Edition
The elevated cardiovascular disease (CVD) risk among people with HIV is even higher than predicted by a standard risk calculator in several groups, including Black patients and cisgender women, according to analyses from a large international clinical trial presented at CROI 2024, held in Denver (poster 781).
The risk for having a first major adverse cardiovascular event (MACE) was also higher than previously